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Abstract
Background and Objective: Invertebrates comprises more than fifty percent of marine animals. Among them, sponges are the most
prolific source of bioactive  compounds.  Suberites  aurantiacus  (S.  aurantiacus)  is an abundant sponge in Mexican Pacific, which has
been  scarcely  studied,  for  this  reason  authors   screened   it   for   its   bioactivities. The current study proposed to determine the
enzymatic inhibition and scavenger, toxic and antibacterial activities from Suberites aurantiacus.  Materials and Methods: S. aurantiacus
samples were collected  in   Magdalena   Bay,   Mexico.   The   ethanolic extract and its fractions were assayed for their antioxidant effect
using DPPH, ABTS and NO assays,  evaluated  their toxicity against Artemia salina (A. salina) and their antibacterial activity against
Staphylococcus aureus (S. aureus), Bacillus subtilis (B. subtilis), Enterococcus  faecalis (E.  faecalis), Enterobacter  aerogenes (E.  aerogenes),
Escherichia  coli (E.   coli)   and  Klebsiella   pneumoniae  (K.   pneumoniae)   as   well   as   their   inhibitory  effect  on "-glucosidase and
"-amylase. Results: The results showed median lethal doses (LD50) against A. salina < 1 mg mLG1  for two fractions and a  moderate 
antibacterial activity against Gram positive bacteria. Conclusion: In view of these results,  S.  aurantiacus   could  be considered a potential
source of antibacterial compounds.
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INTRODUCTION
Natural products have been explored over the years for
their potential applications as food, fragrances, pigments,
insecticides and drugs1. Most of the efforts to discover new
bioactive metabolites  have been focused in plants due to
their relative ease of access. However, since the development
of appropriate scuba techniques, about 50 years ago, the
marine environment has been intensely explored as a source
of new bioactive agents2.
This environment covers a wide range of temperatures,
pressure and nutrients, housing extensive photic and aphotic
zones3, constituting a source of countless products whose
properties include antiviral, antibacterial, antiprotozoal,
antifungal, cytotoxic and antitumor activities4.
Marine invertebrates comprise approximately 60% of all
marine animals, one of the groups with the highest number of
bioactive compounds reported, most of them produced as
defense mechanism. Due to their lack of swimming speed and
physical defense, synthesizing compounds that can be used
to discourage predators confers them an adaptive advantage
in marine environment5.
Sponges (phylum Porifera) are the oldest multicellular
animals and they are present in abundance in tropical reefs,
polar latitudes, freshwater lakes and rivers6. More than 5,300
metabolites has been isolated from sponges7, representing
48.8% of all the new marine invertebrates natural products
discovered between 1990 and 20118.
Suberites  aurantiacus  sponge  belongs  to the
Demospongiae class, the Hadromerida order and the
Suberitidae family. It inhabits estuarine environments and
semi-enclosed bays and is one of the most abundant species
in Mexican Pacific estuaries9. In addition, it is known that
Suberites sponge produce principally sesterpenes10-14,
nevertheless, there is a lack of biological activity studies
concerning sponges from the Suberites  genus in Mexico. For
these reasons, current study proposed to determine the
enzymatic inhibition and scavenger, toxic and antibacterial
activities from Suberites aurantiacus. 
MATERIALS AND METHODS
Preparation of Suberites aurantiacus extract and
fractionation: Sponges were collected in June, 2009 in
Magdalena   Bay,    Baja   California   Sur   at  1.5  m  of  depth.
Dr.  Enrique   Ávila     Torres     collected     and     identified   the
specimens, 675 g of animal material were used to obtain an
ethanolic extract by maceration. The ethanolic extract was
partitioned with water:butanol (1:1), obtaining an aqueous
partition (22.79 g) and butanol  (4.72 g). The organic phase
was mixed and evaporated with silica gel, then fractionated
using a stepwise gradient of CH2Cl2:EtOH (100:0-0:100).
Posteriorly, a Thin Layer Chromatography silica gel (TLC plates)
was performed and all the fractions were compared and
grouped  it into four fractions: E1Bt1 (1.5 g), E1Bt2 (1.2 g),
E1Bt3 (1.4 g) and E1Bt4 (0.66 g).
Antibacterial activity: The antibacterial activity was
determined  by the disk diffusion method using Mueller
Hinton agar. Gram-positive (S. aureus, B. subtilis, E. faecalis)
and    Gram-negative      bacteria      (E.     aerogenes,     E.  coli,
K. pneumoniea) standardized suspension (1.5×108 CFU mLG1)
was applied on the solidified culture  medium and sterile
paper disks (6 mm) were impregnated with 1.5 mg/disk of the
samples. The disk were transferred onto the inoculated agar
plates and incubated at 37EC/24 h, then the resulting
inhibition zone  (clear area  without bacterial growth including
the disk)15. Positive  and negative controls were gentamicin
(15 µg/disk) and dimethyl sulfoxide (DMSO), respectively.
Antioxidant activity: DPPH (2,2-Dipheyl-1-picrylhydrazyl)
radical  scavenging  activity  was  determined   using   100  µL
of  samples   (from   2-0.12   mg  mLG1)  and  100  µL  DPPH
(0.12 mg mLG1) in microplate. The reaction was completed
after 30 min in the dark at room temperature and the
absorbance was read at 517 nm, noting a color to turn from
purple to yellow16. Positive and negative controls were trolox
and methanol, respectively. 
To  determine     ABTS   (2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) radical scavenging
activity, the cation was prepared by mixing 10 mM ABTS stock
solution with 2.45 mM potassium persulfate and leaving the
mixture for 16 h. The ABTS solution was diluted with ethanol
to get an absorbance of 0.7±0.05  at  734  nm.  The assay was
conducted adding 200  µL  of  ABTS  solution  and  20  µL  of 
tested  samples (0.25-2 mg mLG1), measurements were taken
at 734 nm after 6 min in dark16. Trolox (6-Hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) was the control.
Nitric  oxide  (NO)  scavenging  activity was analyzed
using the Griess reaction in microplate. Fifty microliter of
sodium nitroprusside (5 mM)  was  mixed  with  50 µL of the
samples  (2-0.12  mg  mLG1)  and  it   was   incubated   at  room
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temperature for 2 h. After that, 100 µL of Griess reagent was
added  and  the  absorbance  was  read at 550 nm. Two
controls were added: NO production (PBS) and NO inhibition
(trolox).
Toxic activity: Toxic activity was determined by Artemia salina
bioassay. Brine shrimp eggs were hatched in artificial sea
water  and after 48 h incubation in a warm room (27EC),
nauplii  were  exposed   to   three   different  samples
concentration (1000, 100 and 10 µg mLG1) containing 10
organisms/5 mL and incubated at 27EC for 24 h. Vials were
then examined and the number of dead nauplii in each vial
was counted. Controls were artificial sea water, DMSO (1%)
and potassium dichromate15.
Enzyme inhibition assays: The "-glucosidase inhibitory
activity was evaluated according to the chromogenic method
described  by  Kaskoos17  with  some  modifications. After a
pre-incubation at 37EC for 15 min, 50 µL of sample and 50 µL
of "-glucosidase (0.8 U mLG1) were incubated in 96 well plates
at 37EC for 15 min. After that, 50 µL of 625 mM p-nitrophenyl-
"-D-glucopyranoside  (PNPG)  solution  was added to each
well  and   incubated   for   another   15  min.  Then, the
reaction  was   stopped   by  adding  100  µL of 0.2 M NaCO3
into  each   well   and    absorbance   reading   was   recorded
at 405 nm.
The "-amylase  inhibitory activity was evaluated
according to Sudha et al.18 with some modifications. After a
pre-incubation at 37EC for  30  min,  50 µL of sample and 50 µL
of "-amylase (1 U mLG1) was incubated in 96 well plates at
37EC for 15 min. After that, 50 µL of 0.5% starch solution in
phosphate buffer was added to each well and the reaction
was incubated at 37EC for 20 min. The reaction was stopped
with 20 µL of 1 M HCl, followed by the addition of 50 µL of
iodine reagent and absorbance was read at 750 nm.
Statistical analysis: All the experiments were performed in
triplicate  and  the  data were  expressed  as   mean±standard 
deviation  (SD).  The  median  lethal  dose  (LD50),  half
maximum  effective   concentration   (EC50)   and  half
maximum inhibitory concentration (IC50) values were
determined using a probit regression with the SPSS version
17.0 software. 
RESULTS
The present results demonstrated the scavenging effect,
the carbohydrate hydrolyzing enzymes inhibition and the
toxic and bactericide effect of the ethanolic extract and
fractions from S. aurantiacus. The fraction obtained with
CH2Cl2:EtOH (2:8) from butanolic phase showed bactericide
effect only against Gram-positive bacteria, the best activity
was against S. aureus  and  B. subtilis  with 9  mm of inhibition
zone. (Table 1), this sample  also  showed  toxicity in the
Artemia  salina  assay  with  median  lethal  dose  of
637.9±120 µg mLG1 (Table 2). Nevertheless, all the samples
obtained from  S.  aurantiacus  possess a poorly effectiveness
as DPPH, ABTS and NO radical scavengers, since the results
show EC50 higher to 2 mg mLG1. The inhibition of "-amylase
and "-glucosidase show IC50 higher to 2 mg mLG1, while
acarbose  IC50  were  0.12±0.02  and 0.97±0.08 mg mLG1 for
"-glucosidase and "-amylase, respectively. The observed
biological effect for the fraction E1Bt3 is acceptable,
considering that the active compound could be diluted. It is
possible that isolating the active compound or compounds
will provide better effect. 
DISCUSSION
Antibiotic use has contributed significantly to the
increased resistance of many bacterial strains and as a
consequence of an increasing demand in screening for new
therapeutic drugs from natural products. There is a greater
interest towards marine organisms19, only from marine
sponges more than 800 antibiotic compounds have been
isolated20.  For  these   reasons, authors decided to studied  the
Table 1: Bactericidal activities from Suberites aurantiacus
Staphylococcus Bacillus Enterococcus Klebsiella Enterobacter Escherichia
Fractions aureus subtilis faecalis pneumoniae aerogenes coli
Extract - - - - - -
E1Bt1 - - - - - -
E1Bt2 7±0 8±1 7±0 - - -
E1Bt3 10±2 9±0 9±1 - - -
E1Bt4 - - - - - -
Gentamicin 19±1 20±2 10±0 15±1 25±3 16±0
Values are in inhibition zone (mm), n = 3±SD, Fractionation obtained with gradients CH2Cl2:EtOH: E1Bt1(100:0), E1Bt2 (1:1), E1Bt3 (2:8) and E1Bt4 (0:100)
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Table 2: Median lethal doses (LD50) from S. aurantiacus against A. salina
Fractions LD50 (µg mLG1)
Extract >1000
E1Bt1 235.6±30
E1Bt2 >1000
E1Bt3 637.9±120
E1Bt4 >1000
Potassium dichromate 18.0±4
Medial lethal dose (LD50), n=3±SD. Fractionation obtained with gradients
CH2Cl2:EtOH: E1Bt1(100:0), E1Bt2 (1:1), E1Bt3 (2:8) and E1Bt4 (0:100)
antibacterial activity of Suberites aurantiacus   extract and its
fractions using the disk diffusion method, which showed a
moderate  bactericide  effect against Gram positive bacteria
for fractions E1Bt2 and E1Bt3, this could be due to a minority
compound, the sesterpenes have been the more common
isolated natural compounds from sponges with bactericidal
activity10-14. Antibacterial studies from sponges has been
reported since marine natural products started, Burkholder
and Rutzler21 assayed antibacterial activity of 31 sponges and
found a major inhibition of Gram-positive bacteria, due to the
permeability provided by the cell wall or to the membrane
accumulation tactics of Gram negative bacteria22, this was
according to current results and may be due to the many
sterols present in the S. aurantiacus extract23.
Turk et al.24 reported the antibacterial activity of ethanolic
extracts from Antarctic marine sponges, where only 8 out from
the 33 sponges were active with Minimum Inhibitory
Concentration (MIC) values between 4 and 400 µg mLG1, in
contrast to their present study where they studied the
aqueous and organic extracts from tropical marine sponges
against  B.  subtilis  and  E.  coli  and most of the organic
extracts  showed  MIC  values  between 0.1 and 36 µg mLG1 for
B. subtilis25.
According  to  literature,  sponges  produce  high  levels of
cytotoxic chemicals by the emission of mucus containing
toxins  as  defense  of  predation  and  against  fouling
organisms26,  for  this reason the toxic effect of  S.  aurantiacus 
using   the  brine  shrimp lethality assay was determined,
which is one of the most useful tools for the preliminary
assessment  of   toxicity/cytotoxic   of   organic  extracts,
considered   good   candidates   for   the  search  of
antineoplastics when it shows a LD < 1 mg mLG1  15,27. Current
results showed a toxic effect for  fractions  E1Bt1 and E1Bt3,
this could suggest also two different bioactive  compounds
and being that fraction E1Bt2 were not active. In general,
sponge  extracts  have  shown  a  wide variation of lethal
doses, for example, Sonia et al.28, demonstrated the toxic
effect  from  many  sponges  against  A.  salina  nauplii and  
lethal   doses   (LD50)   fluctuating   between 0.5 and 9 mg mLG1
was  observed.
Natural  products  have  been  reported   as  carbohydrate-
hydrolyzing enzymes, associating the observed effects with
the phenolic content and antioxidant activity of the extracts29.
This could explain current results, which did not show
carbohydrate-hydrolyzing enzymes inhibition neither
antioxidant activity. Orhan et al.30 evaluated biological activity
from seven marine sponges from Mediterranean sea and
showed a low radical scavenging activity (>2 mg mLG1).
Shaaban et al.31 evaluated the antioxidant activity by DPPH
and NO methods and the "-glucosidase and "-amylase
inhibitory  effect of different extracts from four marine
sponges and only one  extract  showed  EC50  and  IC50 values
<1 mg mLG1. Berne et al.32 assayed 24 Antarctic marine
sponges for a range of bioactivities, where four showed
inhibitory effect on "-amylase, additionally, the extracts were
tested on a variety of pathogenic and multiresistant Gram-
negative and Gram-positive bacterial strains whereby all the
tested sponge extracts showed weak to moderate inhibitory
activities against at least one strain of the bacteria tested,
nevertheless, the assay was carry out with 20 mg/disk,
obtaining inhibitory zone diameter of 7-13 mm.
Although, sponges have been an interesting source of
bioactive compounds, present study results and studies cited
formerly, showed moderate Bioactivities from different genus
of sponges. Mehbub et al.33 reviewed the marine sponge
derived natural products between 2001 and 2010 and
reported a total of 1,615 new compounds from different
orders of marine sponges with different Bioactivities, which
showed some orders with over 200 bioactive compounds,
meanwhile there are orders with less than 10 bioactive
molecules. From Hadromerida order, the review showed 74
bioactive molecules, 2 and 25 out of them with antibacterial
and cytotoxic activities, respectively.
These studies were according with current study, in which
ethanolic extract and fractions of S. aurantiacus is not as
promising as antiradical and "-glucosidase and "-amylase
inhibitor. Nevertheless, it is moderately active against Gram
positive bacteria and A. salina  nauplii.
CONCLUSION
Marine  invertebrates  have  been   an  important source
of bioactive  metabolites  with  a  wide  spectrum of
interesting activities, in relation to the above, the marine
sponge S. aurantiacus  possesses compounds with bactericidal
effect against Gram negative bacteria and toxic/cytotoxic
activity.  The  best  effect  was   showed   by   the  fraction
E1Bt3 proposing the isolation of bactericidal and/or cytotoxic
compounds from these fraction for futures studies.
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SIGNIFICANCE STATEMENT
The present study reports the bactericidal and toxic
activities of the fractions from Suberites aurantiacus  extract,
which although it is an abundant specie in pacific coast of
Mexico, it had not been study before for these bioactivities. It
aims to expand upon the knowledge concerning the bioactive
profile of sponges from Baja California Sur, what opens the
possibility for the technological use of regional biodiversity.
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